Clinical Trials Browser

Triple Negative Breast Neoplasms × sintilimab × Clear all

NCT07394387 2026-02-06

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT07351487 2026-01-20

Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT04809779 2021-03-22

NeoPD1TNBC

Phase 2 Unknown

Triple Negative Breast Neoplasms